Susquehanna International Group’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,500
Closed -$11.6K 13586
2025
Q4
$11.6K Buy
+11,500
New +$14.3K ﹤0.01% 12042
2023
Q4
Sell
-16,500
Closed -$49.2K 12778
2023
Q3
$49.2K Buy
16,500
+6,100
+59% +$23.2K ﹤0.01% 11314
2023
Q2
$46.4K Buy
+10,400
New +$46.6K ﹤0.01% 11367
2022
Q4
Sell
-10,600
Closed -$28K 12981
2022
Q3
$28K Buy
+10,600
New +$23.9K ﹤0.01% 12471
2022
Q1
Sell
-42,300
Closed -$201K 13447
2021
Q4
$201K Sell
42,300
-47,400
-53% -$191K ﹤0.01% 11436
2021
Q3
$232K Buy
89,700
+7,200
+9% +$19K ﹤0.01% 11165
2021
Q2
$245K Buy
82,500
+53,700
+186% +$178K ﹤0.01% 11183
2021
Q1
$112K Buy
+28,800
New +$147K ﹤0.01% 11801
2020
Q3
Sell
-74,100
Closed -$340K 10806
2020
Q2
$340K Buy
+74,100
New +$481K ﹤0.01% 8137

Other funds holding IFRX

Susquehanna International Group's IFRX Position: Q1 2026 in Review

Susquehanna International Group increased its InflaRx (IFRX) stake by 96% in Q1 2026, buying an estimated $35.7K and bringing the position to 77,114 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #12520.

Susquehanna International Group first reported a position in IFRX in Q2 2020 and has held it in 19 quarters since. The position peaked at $795K in Q2 2023. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Susquehanna International Group held 77,114 shares of InflaRx worth $69K as of Q1 2026.
  • Susquehanna International Group bought 37,741 InflaRx shares in Q1 2026, an estimated $35.7K.
  • InflaRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12520 holding.
  • Susquehanna International Group first reported a position in InflaRx in Q2 2020 and has held it in 19 quarters since.
  • Susquehanna International Group's InflaRx position peaked at $795K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.